nach oben

Archives of Virology

Erschienen in:

01.06.2010 | Original Article

Tetramerization of white spot syndrome virus envelope protein VP33 and its interaction with VP24

verfasst von: Yi Lin, Limei Xu, Feng Yang

Erschienen in: Archives of Virology | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

VP33, also termed VP281, VP37 or VP36B, is a minor envelope protein of white spot syndrome virus (WSSV). Because of its low abundance and lack of a transmembrane domain, we hypothesized that VP33 is likely to be attached to the viral envelope by interaction with other envelope proteins. In this study, we employed far-western blotting and pull-down assays to demonstrate that VP33 interacts with itself, as well as with VP24, which is one of the four major viral envelope proteins. Moreover, a gel-filtration analysis was performed to show that this self-interaction led to the formation of stable VP33 tetramers. These results implied that VP33 tetramers were anchored to the viral envelope through interaction with VP24, suggesting that VP33 may participate in the formation of the WSSV envelope.

Chang PS, Chen HC, Wang YC (1998) Detection of white spot syndrome associated baculovirus in experimentally infected wild shrimp, crab and lobsters by in situ hybridization. Aquaculture 164:233–242CrossRef

Chang YS, Liu WJ, Chou TL, Lee YT, Lee TL, Huang WT, Kou GH, Lo CF (2008) Characterization of white spot syndrome virus envelope protein VP51A and its interaction with viral tegument protein VP26. J Virol 82:12555–12564CrossRefPubMed

Chen J, Li Z, Hew CL (2007) Characterization of a novel envelope protein WSV010 of shrimp white spot syndrome virus and its interaction with a major viral structural protein VP24. Virology 364:208–213CrossRefPubMed

Chen L, Lo CF, Chiu YL, Chen FC, Kou GH (2000) Experimental infection of white spot syndrome virus (WSSV) in benthic larvae of mud crab Scylla serrata. Dis Aquat Org 40:157–161CrossRefPubMed

Chiu WL, Chang W (2002) Vaccinia virus J1R protein: a viral membrane protein that is essential for virion morphogenesis. J Virol 76:9575–9587CrossRefPubMed

Corbel V, Zuprizal, Shi Z, Huang C, Sumartono, Arcier JM, Bonami JR (2001) Experimental infection of European crustaceans with white spot syndrome virus (WSSV). J Fish Dis 24:377–382

Escobedo-Bonilla CM, Alday-Sanz V, Wille M, Sorgeloos P, Pensaert MB (2008) A review on the morphology, molecular characterization, morphogenesis and pathogenesis of white spot syndrome virus. J Fish Dis 31:1–18PubMed

Huang C, Zhang X, Lin Q, Xu X, Hew CL (2002) Characterization of a novel envelope protein (VP281) of shrimp white spot syndrome virus by mass spectrometry. J Gen Virol 83:2385–2392PubMed

Jie ZL, Xu LM, Yang F (2008) The C-terminal region of envelope protein VP38 from white spot syndrome virus is indispensable for interaction with VP24. Arch Virol 153:2103–2106CrossRefPubMed

10.

Leu JH, Yang F, Zhang X, Xu X, Kou GH, Lo CF (2009) Whispovirus. Curr Top Microbiol Immunol 328:197–227CrossRefPubMed

11.

Li Z, Lin Q, Chen J, Wu JL, Lim TK, Loh SS, Tang X, Hew CL (2007) Shotgun identification of the structural proteome of shrimp white spot syndrome virus and iTRAQ differentiation of envelope and nucleocapsid subproteomes. Mol Cell Proteomics 6:1609–1620CrossRefPubMed

12.

Liu QH, Zhang XL, Ma CY, Liang Y, Huang J (2009) VP37 of white spot syndrome virus interact with shrimp cells. Lett Appl Microbiol 48:44–50CrossRefPubMed

13.

Lo CF, Ho CH, Peng SE, Chen CH, Hsu HE, Chiu YL, Chang CF, Liu KF, Su MS, Wang CH, Kou GH (1996) White spot syndrome associated virus (WSBV) detected in cultured and captured shrimp, crabs and other arthropods. Dis Aquat Org 27:215–225CrossRef

14.

Mayo MA (2002) Virus taxonomy-Houston. Arch Virol 147:1071–1076CrossRefPubMed

15.

Mayo MA (2002) A summary of taxonomic changes recently approved by ICTV. Arch Virol 147:1655–1656CrossRefPubMed

16.

Rozen R, Sathish N, Li Y, Yuan Y (2008) Virion-wide protein interactions of Kaposi’s sarcoma-associated herpesvirus. J Virol 82(10):4742–4750CrossRefPubMed

17.

Sahul Hameed AS, Yoganandhan K, Sathish S, Rasheed M, Murugan V, Jayaraman K (2001) White spot syndrome virus (WSSV) in two species of freshwater crabs (Paratelphusa hydrodomous and P. pulvinata). Aquaculture 201:179–186CrossRef

18.

Sahul Hameed AS, Anilkumar M, Stephen ML, Kunthala J (1998) Studies on the pathogenicity of systemic ectodermal and mesodermal baculovirus and its detection in shrimp by immunological methods. Aquaculture 160:31–45CrossRef

19.

Tsai JM, Wang HC, Leu JH, Wang AH, Zhuang Y, Walker PJ, Kou GH, Lo CF (2006) Identification of the nucleocapsid, tegument, and envelope proteins of the shrimp white spot syndrome virus virion. J Virol 80:3021–3029CrossRefPubMed

20.

Tsai JM, Wang HC, Leu JH, Hsiao HH, Wang AH, Kou GH, Lo CF (2004) Genomic and proteomic analysis of thirty-nine structural proteins of shrimp white spot syndrome virus. J Virol 78:11360–11370CrossRefPubMed

21.

van Hulten MCW, Witteveldt J, Peters S, Kloosterboer N, Tarchini R, Fiers M, Sandbrink H, Lankhorst RK, Vlak JM (2001) The white spot syndrome virus DNA genome sequence. Virology 286:7–22CrossRefPubMed

22.

Vázquez MI, Rivas G, Cregut D, Serrano L, Esteban M (1998) The vaccinia virus 14-kilodalton (A27L) fusion protein forms a triple coiled-coil structure and interacts with the 21-kilodalton (A17L) virus membrane protein through a C-terminal α–helix. J Virol 72:10126–10137PubMed

23.

Wan Q, Xu LM, Yang F (2008) VP26 of white spot syndrome virus functions as a linker protein between the envelope and the nucleocapsid of virion by binding with VP51. J Virol 82:12598–12601CrossRefPubMed

24.

Williams O, Wolffe EJ, Weisberg AS, Merchlinsky M (1999) Vaccinia virus WR gene A5L is required for morphogenesis of mature virions. J Virol 73(6):4590–4599PubMed

25.

Xie XX, Yang F (2005) Interaction of white spot syndrome virus VP26 protein with actin. Virology 336:93–99CrossRefPubMed

26.

Xie XX, Yang F (2006) White spot syndrome virus VP24 interacts with VP28 and is involved in virus infection. J Gen Viro 87:1903–1908CrossRef

27.

Xie XX, Xu LM, Yang F (2006) Proteomic analysis of the major envelope and nucleocapsid proteins of white spot syndrome virus. J Virol 80:10615–10623CrossRefPubMed

28.

Yang F, He J, Lin X, Li Q, Pan D, Zhang XB, Xu X (2001) Complete genome sequence of the shrimp white spot bacilliform virus. J Virol 75:11811–11820CrossRefPubMed

29.

Zhou Q, Xu L, Li H, Qi Y, Yang F (2009) Four major envelope proteins of white spot syndrome virus bind to form a complex. J Virol 83(9):4709–4712CrossRefPubMed

Titel: Tetramerization of white spot syndrome virus envelope protein VP33 and its interaction with VP24
verfasst von: Yi Lin
Limei Xu
Feng Yang
Publikationsdatum: 01.06.2010
Verlag: Springer Vienna
Erschienen in: Archives of Virology / Ausgabe 6/2010
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI: https://doi.org/10.1007/s00705-010-0650-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2010

Fibronectin and asialoglyprotein receptor mediate hepatitis B surface antigen binding to the cell surface

Comparative analysis of rabies virus isolates from Brazilian canids and bats based on the G gene and G-L intergenic region

Association of −308G/A polymorphism in the tumor necrosis factor-α gene promoter with susceptibility to development of hantavirus cardiopulmonary syndrome in the Ribeirão Preto region, Brazil

Extrapulmonary tissue responses in cynomolgus macaques (Macaca fascicularis) infected with highly pathogenic avian influenza A (H5N1) virus

Characterization of novel porcine sapoviruses